Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) EBT Margin (2024 - 2025)

Prime Medicine filings provide 2 years of EBT Margin readings, the most recent being 5671.24% for Q4 2025.

  • On a quarterly basis, EBT Margin fell 373464.0% to 5671.24% in Q4 2025 year-over-year; TTM through Dec 2025 was 4422.24%, a 214437.0% increase, with the full-year FY2025 number at 4408.48%, up 215813.0% from a year prior.
  • EBT Margin hit 5671.24% in Q4 2025 for Prime Medicine, down from 4312.82% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 1936.6% in Q4 2024 to a low of 25128.23% in Q3 2024.